Skip to content

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03182140
Acronym
KYSS
Enrollment
1134
Registered
2017-06-09
Start date
2017-07-06
Completion date
2020-03-31
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

long-acting contraception,, unintended pregnancy, satisfaction, bleeding profile, amenorrhea

Brief summary

The main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user satisfaction, taking into account previously used contraceptive methods and reasons for use of Kyleena.

Interventions

DRUGKyleena

Kyleena - intrauterine delivery system containing 19.5 mg LNG

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Women requesting contraception with Kyleena. The woman's informed decision for contraception with Kyleena was made before and independently from the study as per investigator's routine practice * Written informed consent.

Exclusion criteria

* Contraindications for Kyleena according to the local market authorization/SmPC * Mental incapacity to consent and provide data during the observational study * Women participating in an investigational program with interventions outside of routine clinical practice.

Design outcomes

Primary

MeasureTime frameDescription
Overall satisfaction with Kyleena assessed by questionnaireapproximately at 12 months after insertion or at premature discontinuationThe rating is based on the 5-item Likert scale (very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied).

Secondary

MeasureTime frameDescription
Overall satisfaction with Kyleena assessed by questionnaireapproximately 4-12 weeks after insertionThe rating is based on the 5-item Likert scale (very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied).
Ease of insertion assessed by investigatorDay 1The rating is based on the categories easy, slightly difficult, very difficult.
Pain at insertion assessed by participantDay 1The rating is based on the categories none, mild, moderate, or severe
Satisfaction with the menstrual bleeding profile with Kyleena assessed by questionnaireafter approximately 12 months or at premature discontinuation and approximately 4-12 weeks after insertionSatisfaction with the menstrual bleeding profile with Kyleena assessed by women who did and did not experience menstrual bleeding during the last three months when answering the question How satisfied were you with your menstrual bleeding pattern? respectively. The rating is based on the 5-item Likert scale (very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied).

Countries

Belgium, Canada, Germany, Mexico, Norway, Spain, Sweden, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026